Pritmohinder S. Gill

High Impact

Associate Professor

UAMS
Last publication 2025 Last refreshed 2026-03-28

faculty

21 h-index 47 pubs 2,197 cited

Research Areas

Links

ORCID Lab Website

OverviewAI-generated summary

Pritmohinder S. Gill's research investigates the molecular underpinnings of neurodevelopmental disorders, with a particular focus on autism spectrum disorder (ASD). His work utilizes integrated transcriptomic profiling, examining both mRNA and microRNA expression, to identify novel targets and networks associated with these conditions. Recent publications explore the role of microRNAs in immunomodulation within ASD and the transcriptomic signatures of mitochondrial dysfunction in affected individuals.

His research also extends to the practical implementation of pharmacogenomics in clinical settings. Gill has contributed to studies assessing the integration of pharmacogenomics into multidisciplinary teams, including experiences at Arkansas Children’s Hospital. His scholarship metrics include an h-index of 21, with over 2,193 total citations across 47 publications, designating him as a highly cited researcher. Key collaborators include Shannon Rose and Jeffery L. Clothier from the University of Arkansas for Medical Sciences.

Metrics

  • h-index: 21
  • Publications: 47
  • Citations: 2,197

Selected Publications

  • Transcriptomic Signatures of Mitochondrial Dysfunction in Autism: Integrated mRNA and microRNA Profiling (2025)
    1 citation DOI OpenAlex
  • Pharmacogenetics (2024)
    DOI OpenAlex
  • Contributors (2024)
    DOI OpenAlex
  • Integrated microRNA–mRNA Expression Profiling Identifies Novel Targets and Networks Associated with Autism (2022)
    13 citations DOI OpenAlex
  • Identification of DCAF1 by Clinical Exome Sequencing and Methylation Analysis as a Candidate Gene for Autism and Intellectual Disability: A Case Report (2022)
    2 citations DOI OpenAlex
  • Multidisciplinary Consulting Team for Complicated Cases of Neurodevelopmental and Neurobehavioral Disorders: Assessing the Opportunities and Challenges of Integrating Pharmacogenomics into a Team Setting (2022)
    6 citations DOI OpenAlex
  • MicroRNA Expression Profiles in Autism Spectrum Disorder: Role for miR-181 in Immunomodulation (2021)
    20 citations DOI OpenAlex
  • Molecular Dysregulation in Autism Spectrum Disorder (2021)
    21 citations DOI OpenAlex
  • Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital (2021)
    24 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

56 Collaborators 29 Institutions 10 Countries

Top Collaborators

View profile →
View profile →

Similar Researchers

Based on overlapping research topics

Jeffery L. Clothier University of Arkansas for Medical Sciences
Autism Spectrum Disorder Research Bioinformatics and Genomic Networks Pharmacological Effects and Toxicity Studies
Good match 4 shared topics
Jeffrey Clothier University of Arkansas for Medical Sciences
Autism Spectrum Disorder Research Bioinformatics and Genomic Networks Pharmacological Effects and Toxicity Studies
Good match 4 shared topics
Ana Regina Cabrera University of Arkansas at Fayetteville
MicroRNA in disease regulation Mitochondrial Function and Pathology Genomics and Chromatin Dynamics
Good match 4 shared topics
Chhanda Bose University of Arkansas for Medical Sciences
MicroRNA in disease regulation Mitochondrial Function and Pathology Pharmacological Effects and Toxicity Studies
Related 4 shared topics
Hannah Stovall Hendrix College
Mitochondrial Function and Pathology Pharmacological Effects and Toxicity Studies Metabolism and Genetic Disorders
Related 3 shared topics
Lee Ann MacMillan‐Crow University of Arkansas for Medical Sciences
Mitochondrial Function and Pathology Pharmacological Effects and Toxicity Studies Metabolism and Genetic Disorders
Related 3 shared topics